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Conventionally, deep venous thrombosis (DVT) is
treated with an intravenous infusion of unfractionated
heparin for at least 5 days, followed by a course of oral
anticoagulants. Hospital admission and bed rest for
the duration of intravenous infusions have been rec-
ommended with the goal of avoiding leg movement
to protect patients from pulmonary embolism. This
traditional management of DVT has changed consid-
erably since the approval of subcutaneous administra-
tion of low molecular weight heparins (LMWHs) for
the treatment of DVT. The new approach includes
home treatment in selected cases.1,2 Patients and their
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Objective: The purpose of this randomized controlled trial was to evaluate the benefits of
compression and walking exercises in comparison with bed rest in the acute stage of
proximal deep venous thrombosis (DVT).
Methods: Forty-five patients with proximal DVT that was proved with compression ultra-
sound scan or phlebography were randomized into three groups. Group A consisted of
15 patients who received inelastic compression bandages (Unna boots on the lower leg,
adhesive bandages on the thigh), and group B consisted of 15 patients who received
thigh-length compression stockings, class II. Group C consisted of 15 patients who
underwent bed rest and no compression. All patients received dalteparin, 200 IU/kg per
body weight, subcutaneously every 24 hours. The clinical characteristics of the three
groups were comparable. Primary end points were the reduction of pain assessed daily
with the Visual Analogue Scale and the Lowenberg test, the reduction of leg circumfer-
ence at the ankle and calf levels, and the improvement of clinical scores. The daily walk-
ing distance was measured with a pedometer. Safety parameters were ventilation-perfu-
sion scans and duplex ultrasound scans performed on days 0 and 9.
Results: The daily walking distance was between 600 and 12,000 m in the compression
groups and averaged 66 m in the bed rest group. The pain level showed a statistically sig-
nificant reduction starting after the second day in the compression groups (A and B) and
after 9 days in the bed rest group C (P < .05). The same was true for the measurement
of leg circumference. Improvement of the clinical scores was significantly better in the
compression groups compared with the bed rest group (P < .01). There was no signifi-
cant difference concerning the occurrence of new pulmonary emboli and regression of
thrombus diameter. Progression of thrombi in the femoral vein was greater and occurred
more frequently in the bed rest group than in the other two groups (P = not significant).
Conclusion: Mobile patients with acute proximal DVT treated with low molecular weight
heparin should be encouraged to walk with compression bandages or medical compres-
sion stockings. The rate of resolution of pain and swelling is significantly faster when
the patient ambulates with compression. The risk of pulmonary embolism is not signif-
icantly increased by this approach. (J Vasc Surg 2000;32:861-9.)
861
From the Dermatological Department, Wilhelminenspital,a and
Angio Bellaria.b
Competition of interest: nil.
Supported by a grant of the German Society of Phlebology.
Presented at the Twelfth Annual Meeting of the American
Venous Forum, Phoenix, Ariz, Feb 3-6, 2000.
Reprint requests: Hugo Partsch, MD, Professor of Dermatology,
Wilhelminen Hospital, A 1171 Vienna, Austria (e-mail:
Hugo.Partsch@der.wil.magwien.gv.at).
Copyright © 2000 by The Society for Vascular Surgery and The
American Association for Vascular Surgery, a Chapter of the
International Society for Cardiovascular Surgery.
0741-5214/2000/$12.00 + 0 24/6/110352
doi:10.1067/mva.2000.110352
relatives are instructed in the subcutaneous adminis-
tration of these new drugs, but specific guidelines
regarding the patient’s ambulation are lacking.
Questions that include whether these individuals
should stay in bed, walk around, or wear any leg com-
pression devices are not routinely addressed.
In several prospective cohort studies in which
consecutive patients with DVT were investigated
with repeated lung scanning, we were able to
demonstrate that there is no increased danger of pul-
monary embolism if mobile patients are treated with
LMWH and keep walking with compression ban-
dages regardless of the size or location of the throm-
bi.3-5 These findings have been confirmed by recent
randomized studies in which bed rest is compared
with compression and walking.6,7
It has been our experience for many years that
patients with DVT recover much faster when they
are encouraged to walk with firm compression ban-
dages. However, until now, evidence-based data
proving the advantages of active walking exercises
with compression have been lacking. This article
presents preliminary results of a randomized con-
trolled trial in which bed rest is compared with walk-
ing exercises and compression.
METHODS
Study design. This study is a randomized,
unblinded, controlled trial in which three groups of
adjuvant treatment modalities in patients with acute,
symptomatic proximal DVT are compared:
• Inelastic Unna boot bandages + walking exercises
(group A)
• Elastic compression stockings + walking exercises
(group B)
• Bed rest and no compression (group C)
The trial was designed as a multicenter study and
approved by the local Institutional Review Boards at
each center. The following data represent the results
from an interim analysis and have been collected
entirely from the center in Vienna. Since this manu-
script was originally presented, eight more patients
have been enrolled.
Patients. We considered 148 consecutive mobile
patients older than 18 years with proximal DVT
(thrombosis of the popliteal or more proximal deep
veins of the legs) that was documented with com-
pression ultrasound scan or phlebography for enroll-
ment in the study. The duration of symptoms had to
be less than 14 days. Patients were excluded from
the study if compression or heparin therapy had
already started, if there was an indication for throm-
bolysis or thrombectomy, and if they had massive
symptomatic pulmonary embolism or severe con-
comitant diseases. They were also excluded if the
ankle-brachial Doppler scan index was lower than
0.8, if they were pregnant or breast-feeding, or if
there was a contraindication for compression, anti-
coagulation, or both. Randomization was per-
formed with sealed envelopes, allocating 15 patients
into each treatment group for an interim analysis.
Anticoagulation was started in each patient
immediately after proximal vein thrombosis had
been documented objectively by color-coded duplex
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Fig 1. Intensity of pain during the 9-day treatment period for each of the three groups measured with
VAS (100 mm = maximal degree of pain, mean ± SD). In the compression groups significant differ-
ences compared with day 0 start on day 1; in the bed rest group differences start on day 5. Analysis of
variance of day 9 under control of day 0: groups A/B, A/C, B/C, not significant (P = .06).
scan imaging with compression. Additional contrast
phlebography was used in 3 patients, isotopic phle-
bography in 11, and magnetic resonance imaging
phlebography in 10.
Treatment regimens. All patients received sub-
cutaneous injections of dalteparin (Fragmin), 200
IU/kg per body weight, once every 24 hours for a
minimum of 6 days (mean, 8.5 ± 0.9 days). They
also received overlapping oral anticoagulants
(Marcoumar) with doses adjusted to reach interna-
tional normalized ratio values between 2.0 and 3.0. 
In group A, tight Unna boot bandages (Varicex
F zinc plaster, 10 cm × 10 m) were applied on the
lower leg and covered with a short-stretch bandage
(Rosidal K, 10 cm × 5 m). The mean pressure on the
distal lower leg, which was measured with an Oxford
pressure monitor in several patients, was 50 mm Hg.
An adhesive short-stretch bandage (Panelast, 10 cm
× 5 m) was applied with considerable pressure over
the knee and up to the groin. This bandage was
changed every 3 days.
Group B received ready-made thigh-length com-
pression stockings, class II (Sigvaris 503), which
were adapted to the individual leg size. They were
worn both day and night. Both groups were encour-
aged to walk as much as possible on the ward and on
the hospital grounds.
In group C, compression bandages were started
only after the ninth day. Patients were advised to stay
in bed, but were allowed to get up to use the toilet.
The daily walking distances were measured with a
pedometer in each group.
End points and outcome measures. During
the 9 days of the study, patients underwent several
examinations. These included daily measurements of
walking distance with a pedometer and of the pain
level, which was assessed with the Visual Analogue
Scale (VAS) and the bilateral Lowenberg test.8 On
days 0, 3, 6 and 9, clinical scores and leg circumfer-
ence were measured. Additional study-related inves-
tigations performed on days 0 and 9 included com-
pression sonography and ventilation-perfusion
(V/Q) lung scans. 
The changes in pain, of leg circumference, and
of the clinical scores were chosen as primary end
points. The occurrence of new pulmonary emboli
compared with a baseline scan and changes of
thrombus extension in the femoral vein were taken
as safety parameters.
Pain was assessed daily at the same time with two
methods: The spontaneous sensation of pain was
assessed by the patient on a VAS and in a more
objective way with a modified Lowenberg test.9 A
cuff was applied on each calf without removing ban-
dages or stockings. Pressure was applied, and the
value at which the patient perceived pain in each calf
was recorded. The measurements were repeated
within a few minutes, and the mean value was calcu-
lated. The difference between the thrombosed and
the healthy leg was calculated and used for analysis.
JOURNAL OF VASCULAR SURGERY
Volume 32, Number 5 Partsch and Blättler 863
Fig 2. Degree of discomfort assessed with Lowenberg test for each patient in which the normal leg
was compared with the involved leg. The differences between the findings in the normal versus the
affected leg for each patient are depicted (mean ± SD). Statistically significant improvement compared
with day 0 is reached in groups A and B on day 2. In group C there is no significant difference up to
day 9. Analysis of variance of day 9 under control of day 0: A/C, P < .001; A/B and B/C, P < .01.
Clinical scores were calculated for the following
seven symptoms: (1) pain during walking, (2)
painful foot sole, (3) painful calf palpation, (4) sub-
fascial edema, (5) prefascial edema, (6) increase of
skin temperature, and (7) redness/cyanosis. The
severity score comprised four stages (absent, mild,
marked, and severe) so that a maximal score of 28
could be reached. Prefascial edema was defined as a
palpable indentation of the skin after firm pressure
was applied for more than 10 seconds by the thumb.
An increase of the consistency of the calf palpated in
a relaxed lying position of the patient was defined as
subfascial edema. Circumference of the lower leg was
measured at the ankle and at midcalf level. 
We measured the distance of the tip of the throm-
bus from the saphenofemoral junction with compres-
sion sonography (Diasonics VST Master Series;
Milipita, Calif) in those cases where thrombi did not
extend into the pelvis. The largest diameter of the clot
during compression and the largest diameter of the
vein were measured 10 cm below the tip of the
thrombus or, in cases with iliac involvement, from the
groin. By scanning down the superficial femoral vein
in a transverse view using compression maneuvers
with the duplex scan probe, we located the tip of the
thrombus at the site of decreased compressibility.
Perfusion lung scans with technetium-99m–
labeled microspheres were performed, with ventila-
tion scans with labeled aerosols in case of perfusion
defects. The assessment of compression ultrasound
scan and of V/Q scans was performed by observers
who were unaware of the patient’s treatment.
Complete blood counts were obtained twice weekly. 
Statistical analysis. According to the results of a
previous study,9,10 the statistical power was calculat-
ed as 71% and 65%, respectively, for a sample size of
60 and a two-sided 5% significance level for the mean
values of the differences in the VAS pain scale and the
Lowenberg test. For the analysis of treatment effects,
analysis of variance was calculated. For nominal data,
the Pearson and the χ2 tests were calculated.
RESULTS
Patients
Of 148 eligible patients admitted because of
proximal DVT between August 1998 and August
1999, 45 gave written consent to participate in this
study. The baseline characteristics of the treatment
groups were similar (Table I).
Table II shows the average daily walking distance
in the three groups. The walking distance varies
between 500 and 12,000 m in the compression
groups and is significantly higher than in the bed
rest group.
Primary end points
Pain. The degree of spontaneous pain as docu-
mented by VAS in the three treatment groups is
shown in Fig 1. In groups A and B, pain levels, com-
pared with day 0, start to be significantly lower
already on day 1; in group C, the levels are lower on
day 5. The use of bandages seems to have a more
pronounced effect than the use of stockings.
The Lowenberg test assesses a more specific per-
ception of pain. The difference in the readings
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Table I. Baseline characteristics of patients according to treatment group 
Group A: Unna Group B: compression Group C: bed rest, no
boot (n = 15) stocking (n = 15) compression (n = 15)
Age (y) 59.2 ± 19.80 61.7 ± 19.23 52.2 ± 16.87
Weight (kg) 80.53 ± 11.08 80.0 ± 15.52 86.0 ± 10.8
Female/male 7/8 5/10 4/11
No./total no.(%)
Most proximal thrombi pelvis/cava 2/0 (13.3/0) 5/1 (33.3/6.6) 4/1 (26.6/6.6)
Left side 11 (73) 8 (53) 9 (60)
Previous DVT
Same leg 3 (20) 3 (20) 1 (6.7)
Contralateral leg 4 (26.7) 3 (20) 4 (26.7)
Previous surgery 1 (6.7) 1 (6.7) 1 (6.7)
Immobility, trauma 5 (33.3) 8 (53.3) 7 (46.7)
Travel 3 (20) 4 (26.7) 1 (6.7)
Cancer 3 (20) 2 (13.3) 0
Oral contraceptives 1 (6.7) 1 (6.7) 3 (20)
Dyspnea at admission 4 (26.7) 3 (20) 3 (20)
between the healthy and the diseased leg is shown in
Fig 2. The reduction of pain is slight without com-
pression, and there is no further decrease during the
subsequent 7 days of bed rest. Compression with
stockings leads to rapid and almost complete relief.
Compression with bandages has the same initial
effect but continues to improve contrary to the
other treatment groups. Statistically significant dif-
ferences, compared with day 0, are reached in
groups A and B on day 2. In group C, there is no
significant difference up to day 9.
Leg circumference. The differences between the
circumferences of the diseased leg and the healthy
leg at the ankle and at calf level give an objective
parameter for the edema caused by DVT. On day 9
the reduction of swelling is significantly more pro-
nounced in the compression groups compared with
the bed rest group (Table III). The decrease of the
circumference at calf level is more pronounced in
group A, whereas there is no difference between
Unna boot and stockings at the ankle level.
Clinical scores. In both compression groups,
the clinical score is significantly improved. The score
is more pronounced with Unna boots than with
compression stockings (Table III).
Safety parameters
Lung scans and duplex scans. No significant dif-
ferences are found concerning the frequency of new
pulmonary emboli, all clinically silent, and the throm-
bus diameter measured with duplex scan. The rate
and amount of thrombus extension or regression in
patients with DVT in the femoral vein are shown in
Fig 3. Thrombus progression is observed in 4 (31%)
of 13 patients in the Unna boot group, in 1 (11%) of
9 patients in the stocking group, and in 4 (40%) of 10
patients in the bed rest group. The longest extension
of the thrombi is found in the bed rest patients. All
these changes are not statistically significant.
Side effects. Three patients in the Unna boot
group (20%) and five patients in the stocking group
(33.3%) reported local pain due to friction or showed
irritation of the skin. In no case was this a cause to
stop treatment. No major bleeding complications or
relevant changes of blood count were observed.
DISCUSSION
The results of several controlled trials suggest
that subcutaneous LMWH in selected, uncomplicat-
ed patients with DVT is as safe and effective as intra-
venous unfractionated heparin, and that most
patients can be treated as outpatients or discharged
early.1,2 Similar conclusions were also drawn from
studies in which patients with pulmonary embolism
were included.11,12 The amount of physical activity
of the patients is not addressed in any of these stud-
ies. Outpatient guidelines include patient counseling
regarding LMWH injections and oral anticoagula-
tion, but no specific advice regarding leg compres-
sion and ambulation is available to the patient. One
important study demonstrated that compression
stockings are able to dramatically reduce the fre-
quency of the post-thrombotic syndrome some years
after proximal DVT, but compression therapy was
started only several days after hospital admission.13
There is an old tradition in continental Europe
to treat mobile patients who have acute DVT with
compression bandages and walking exercises. As
early as 1910 and years before heparin was discov-
ered, Heinrich Fischer14 recommended zinc plaster
bandages, which he learned about from his teacher
Unna, to treat patients with thrombosis, speculating
that firm external compression would affix the clots
to the vein wall. This idea is also the reason why in
this study, continuous daylong and nightlong com-
pression of the whole leg was performed, both with
bandages and stockings. We do not know if in the
future calf stockings worn only during daytime will
perhaps reveal similar results.
It has been our routine for many years not to
immobilize patients with acute proximal DVT as
long as they are mobile, regardless of size, extent, or
morphology of the thrombi. Compared with data in
the literature that are based on bed rest, we found
that even patients with iliofemoral DVT did not
have a higher risk of scintigraphic or fatal pulmonary
embolism if treated with compression, walking exer-
cises, and either unfractionated heparin given subcu-
taneously3 or LMWH.4,5,10 These findings were
recently confirmed by two randomized controlled
trials that showed no statistically significant differ-
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Table II. Daily walking distance in meters measured with pedometer (mean ± SD)
Group B: Group C: bed rest, 
Group A: Unna boot compression stocking no compression Statistical difference
Walking distance, day 0 1793.0 ± 1425.0 2058.0 ± 1649.0 66.0 ± 112.1 A/C, P < .001; B/C, P < .001
Walking distance, day 9 4048.5 ± 2947.0 3659.9 ± 2905.0 179.3 ± 160.6 A/C, P < .001; B/C, P < .001
ences of the rate of new pulmonary emboli between
bed rest and walking with compression in 129 and
122 patients, respectively.6,7
However, most centers, up to now, recommend-
ed bed rest because of the fear of pulmonary
embolism. No controlled study has been available
until today that compared safety and efficacy of
these two management modalities. 
All eligible patients received detailed information
concerning the nature of this trial, including the
risks associated with a 9-day period of bed rest. It
was possible to enroll only one third of the eligible
patients after they understood the nature of this
trial. Two thirds were not willing to undergo bed
rest for 9 days.
Our results of this study indicate that compres-
sion and walking exercises reduce pain and swelling
in patients with proximal DVT much faster and
more effectively than bed rest does without a greater
risk of pulmonary embolism. With VASs (Fig 1) and
the Lowenberg test (Fig 2), our results show that
after 4 days the average pain level after compression
with Unna boots is in the same range as for the bed
rest group after 9 days. Bandages are more effective
than compression stockings. However, compression
stockings also lead to a significantly faster and more
extensive pain reduction than does bed rest.
Pain results from an increase of compartmental
pressure resulting from congestion of muscle veins by
thrombi and trapped blood. It is generally thought
that pain is reduced if the thrombosed leg is immobi-
lized. Because the spontaneous decrease of compart-
mental pressure is slow, a rapid relief of inducible pain,
assessed with the Lowenberg test, cannot be expected.
External leg compression—in conjunction with walk-
ing—leads to a palpable reduction of subfascial consis-
tency that is probably due to a lowering of compart-
mental pressure and thus to a decrease of pain. Indirect
support for this assumption is that the decreased sub-
fascial lymph transport in patients with DVT and with
post-thrombotic syndrome is enhanced by firm exter-
nal compression.15 Pain assessed with VAS decreased
more slowly than pain monitored with the Lowenberg
test. Compression with stockings has a somewhat less
sustained effect than compression with bandages. We
speculate that phenomena other than compartmental
pressure (eg, inflammatory processes) may play a role.
Compression with firm, inelastic bandages has a
greater effect on such phenomena than compression
with elastic hosiery.
A statistically significant decrease in the degree of
leg swelling was observed in the compression and
walking groups. After 9 days, measurable edema dis-
appeared completely in the bandage group. A signif-
icant reduction of the circumference of the leg with
DVT, which is remarkably extensive in the ankle
area, is also observed after compression stockings.
Both pain and swelling are important parame-
ters, especially for the patients’ perception of their
disease. The same is true for the clinical scores,
which also showed a significantly superior course of
regression for the compression groups compared
with the bed rest group.
Baseline lung scans did not show significant dif-
ferences among the treatment groups. Only a few
patients (10) reported some degree of dyspnea dur-
ing walking. Most of the pulmonary emboli that
were proved with scintigraphy were therefore clini-
cally silent. The occurrence of new emboli detected
by the second lung scan was not significantly differ-
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Fig 3. Change of thrombus length in the femoral vein (cm) measured with duplex sonography. The digits
in the bars reflect the number of patients showing regression (left) or progression (right from the center).
ent in the three groups. No clinical, life-threatening,
or fatal emboli were observed in the study.
An interesting trend was seen in the duplex scan
findings, which, we think, has to be proved by a larg-
er series. Because of the problem of exactly defining
the proximal tip of the thrombus in cases of throm-
bi extending proximal to the inguinal fold, only
patients with femoral vein involvement were evaluat-
ed. Progression and extension of the thrombus were
more frequently observed in the bed rest group.
External leg compression has several physical
effects, which have been measured in different
experiments. It counteracts edema formation and
leads to a narrowing of superficial and deep veins,
which is demonstrated with phlebography.
Inelastic material such as zinc plaster is more effec-
tive than elastic material for the reduction of local
blood volume.16 Blood flow velocity increases,
even when a patient is in the supine position and is
wearing thromboprophylactic stockings of low
pressure.17 It must be stressed that all positive
effects of compression are tightly connected with
the intentional and aggressive walking exercises
that those patients were encouraged to perform.
The rhythmic acceleration of venous flow velocity
with every step is certainly a very potent mecha-
nism to prevent venous stasis from promoting
propagation of thrombi. Compression and early
ambulation are accepted as effective measures in
primary prevention, but they have been totally
neglected or underestimated as very potent tools
of therapy in the acute phase of DVT.
Thrombus propagation is observed in about 20%
of patients, despite adequate heparin treatment if
patients are mobilized after several days, but only in
1% if early ambulation is instituted.18 Hull et al19
have shown that prolonging the partial thrombo-
plastin time to at least twice the control value with
intravenous heparin within 24 hours is critical in pre-
venting thrombus propagation. Thrombus propaga-
tion depends on the level of anticoagulation and is
certainly also influenced by the amount of stasis,
especially in this crucial time. Therefore, we consid-
er mobilization of the patient with DVT immediate-
ly after diagnosis and application of LMWH essential
and not 24 hours later.
Forty-four patients in this study, including 11
patients with pelvic and two with caval thrombosis,
were treated in the hospital; one was treated on a
daycare basis. During the study period of 9 days, no
severe events were observed. The proposed treat-
ment regimen of LMWH, compression, and walking
exercises could also have been performed on an out-
patient basis without any loss of quality. The eco-
nomic advantages of complete or partial outpatient
treatment are evident and will gradually change the
current concept of hospital treatment of DVT.20
However, clear guidelines concerning selection of
patients for hospital or home therapy are needed.21
We conclude from this study that compression and
walking in mobile patients with DVT lead to a faster
reduction of leg swelling and pain without an
increased risk of pulmonary embolism and should
therefore replace the old tradition of bed rest.
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Table III. Differences in circumference between the two legs at ankle and calf level (cm), clinical scores,
V/Q scan, and thrombus diameter on days 0 and 9 (mean ± SD)
Group A: Group B: Group C: Statistical 
Unna boot stocking bed rest difference
Difference of circumference, ankle, day 0 1.40 ± 1.33 1.93 ± 1.53 1.47 ± 1.03 ns
Difference of circumference, ankle, day 9 –0.27 ± 0.82 –0.30 ± 0.80 1.20 ± 1.28 A/C, P < .001, 
B/C, P < .001, 
A/B, ns
Difference of circumference, calf, day 0 3.17 ± 1.81 2.93 ± 1.45 2.67 ± 1.50 ns
Difference of circumference, calf, day 9 0.03 ± 0.92 0.90 ± 1.28 2.30 ± 1.53 A/C, P < .001, 
B/C, P < .001, 
A/B, P < .01
Clinical score, day 0 17.0 ± 3.4 19.3 ± 2.5 18.9 ± 3.7 ns
Clinical score, day 9 7.7 ± 1.2 9.5 ± 1.9 12.1 ± 3.9 A/C, P < .001, 
B/C, P < .01, 
A/B, P < .05
High probability scan, day 0 12 9 9 ns
New PEs, day 9 2 1 1 ns
Thrombus diameter, day 0 9.4 ± 2.3 10.3 ± 2.5 11.0 ± 4.2 ns
Thrombus diameter, day 9 8.1 ± 2.2 9.1 ± 2.4 8.9 ± 3.5 ns
ns, Not significant; PE, pulmonary emboli; V/Q, ventilation-perfusion.
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DISCUSSION
Dr John A. Heit (Rochester, Minn). I congratulate
Professor Partsch and colleagues on a well-designed study.
The strengths of the study can be summarized as follows.
The study objective addressed a relevant clinical problem,
and the study design was a randomized clinical trial. The
study methods included objective diagnostic testing for
acute proximal deep vein thrombosis, appropriate inclusion
and exclusion criteria, and anticoagulation therapy that is
the current standard of care. The study interventions
included the current standard of care in Europe (hospital-
ization with bed rest) as well as two additional groups (ie,
Unna boot and graduated compression stocking therapy),
which reflected more recent trends in care (eg, ambulatory
outpatient LMWH therapy). The primary study end points
of change in pain (as measured by a visual analogue scale
and the Lowenberg test) and change in leg circumference
were objective and quantifiable. However, the “clinical
scores” were subjective and therefore must be interpreted
with caution since the study was not blinded. Measured
walking distance was significantly greater for the Unna
boot and the compression stocking groups compared with
the bed rest group. Finally, the randomization appears to
have been successful, and the primary end points were con-
sistent and in favor of ambulation with either Unna boot or
compression stocking therapy over bed rest.
The weaknesses of the study are as follows. Only about
one third (45/148) of eligible patients were enrolled. The
low enrollment could affect the generalizability of the
study conclusions. To address this issue, the authors should
provide additional information about the 103 patients who
did not participate. The authors should also provide more
information on how the graduated compression stockings
were fitted. Were the stockings fitted based on measure-
ments of the unaffected leg? Finally, the authors should
include the duplex ultrasound and ventilation perfusion
lung scan methods and the interpretation criteria. Were
lung scans interpreted as diagnostic of pulmonary
embolism only if the scan was a “high probability” scan?
What were the criteria for diagnosing a “new” pulmonary
embolism? The authors found that the three groups did
not differ significantly in the rate of proximal thrombus
propagation or change in thrombus size (as measured by
serial duplex ultrasounds), or evidence of new pulmonary
embolism (as measured by serial lung scans). This finding
should be interpreted with caution because the sample size
was too small to exclude a significant difference.
In summary, I believe the authors’ major conclusions
are correct. Moreover, the conclusions are supported by at
least two other large randomized clinical trials (Koopman
1996, Levine 1996) and a recent cohort study (Wells
1998). I urge the authors to enlarge the sample size and
include a longer duration of clinical follow-up. I also urge
the authors to determine the cumulative incidence of
venous stasis syndrome (VSS) among the three intervention
groups. Although one trial found that compression stocking
therapy reduced the 2-year cumulative incidence of VSS,
20% of patients receiving compression stockings still devel-
oped mild to moderate VSS (Brandjes 1997). However,
compression stocking therapy was delayed for 2 to 3 weeks.
“Immediate” compression therapy, as performed in this
study, may further reduce the incidence of VSS.
Dr Hugo Partsch. Thank you very much Dr Heit for
your very valuable comments and for your kind words. To
answer your questions:
First, what happened to the other patients who were
not included in this study? These were patients who were
treated the same way as we do it now for about 30 years
already. All these patients are admitted to our ward, they
get anticoagulation, and they remain walking. Since our
institution has become popular for not putting patients
into bed, this was also the reason why we were able only
to find 45 patients who accepted the risk of being put into
bed by randomization.
Your second question concerning the stocking: the
stocking was adopted to the involved leg, not to the oppo-
site leg, and the stocking stayed on these patients overnight. 
Concerning perfusion ventilation lung scan, yes, our
sample size was much too small to get any kind of infor-
mation out of that, but several times we have published
our findings of ventilation perfusion scanning in more
than 1000 patients now, before, and after 9 days of our
kind of treatment, not putting patients into bed.
Comparing these data with the literature there is no sig-
nificant difference. As I have mentioned there is one study
from Basle and one from Schellong in Germany where the
patients were randomized into a bed rest group and a
walking group. The authors were also not able to find
higher frequency of pulmonary embolism in walking
patients compared with bed rest patients. 
Your fourth point was if we would like to extend the
study. Yes, certainly this would be a good idea because
there may be some difference also concerning the devel-
opment of post-thrombotic syndrome. As you have men-
tioned in the study from Brandjes, the patients started to
be treated with stockings only after 9 days.
Thank you very much for your comments.
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